surmount-1 trial tirzepatide obesity without diabetes weight loss for Obesity: Highlights from the SURMOUNT-1: Tirzepatide Drastically Reduces Weight

She emphasis that it should be taken regularly and to follow your physicians dosage advice

The most common adverse effects of tirzepatide are gastrointestinal in nature, with rates varying by dose and population

Treatment with tirzepatide, a novel glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) dual receptor agonist, has been shown to improve sleep apnea severity and related cardiometabolic issues in people with moderate-to-severe obstructive sleep apnea (OSA) and obesity, according to findings from the SURMOUNT-OSA trial, which were presented during a late-breaking symposium on Friday, June 21, at the 84 th Scientific Sessions

Heart palpitations or irregular heartbeat

We have delivered medicines to more than 90 countries

People can try the following steps to reduce fatigue while taking Mounjaro: Monitor blood sugar A person should watch for signs of low blood sugar, such as shakiness, sweating, or generalized weakness